MA1-80216

antibody from Invitrogen Antibodies

Targeting: ESR1 ER-alpha, Era, ESR, NR3A1

Provider product page for MA1-80216

Western blot

Immunocytochemistry

Immunohistochemistry

Antibody data

Antibody Data
Antigen structure
References [47]
Comments [0]
Validations
Western blot [1]
Immunocytochemistry [1]

Submit

Product number: MA1-80216 - Provider product page
Provider: Invitrogen Antibodies
Product name: Estrogen Receptor alpha Monoclonal Antibody (6F11)
Antibody type: Monoclonal
Antigen: Recombinant full-length protein
Description: Heat-mediated antigen retrieval using a sodium citrate buffer (pH 6.0) is recommended for the staining of paraffin sections. A suggested positive control for this product is breast carcinoma. Mouse anti Human estrogen alpha antibody, clone 6F11 recognizes the human estrogen receptor alpha chain (ERalpha), also known as the estradiol receptor or nuclear receptor subfamily 3 group A member 1.
Reactivity: Human, Mouse, Rat
Host: Mouse
Isotype: IgG
Antibody clone number: 6F11
Vial size: 100 µL
Concentration: Conc. Not Determined
Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

ESR1 protein structure - MA1-80216 shown in red.

Submitted references The bone microenvironment increases phenotypic plasticity of ER(+) breast cancer cells.

Bado IL, Zhang W, Hu J, Xu Z, Wang H, Sarkar P, Li L, Wan YW, Liu J, Wu W, Lo HC, Kim IS, Singh S, Janghorban M, Muscarella AM, Goldstein A, Singh P, Jeong HH, Liu C, Schiff R, Huang S, Ellis MJ, Gaber MW, Gugala Z, Liu Z, Zhang XH
Developmental cell 2021 Apr 19;56(8):1100-1117.e9

Estrogen-Dependent Functional Spine Dynamics in Neocortical Pyramidal Neurons of the Mouse.

Ye Z, Cudmore RH, Linden DJ
The Journal of neuroscience : the official journal of the Society for Neuroscience 2019 Jun 19;39(25):4874-4888

St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.

Soares M, Correia J, Peleteiro MC, Ferreira F
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Mar;37(3):4053-64

Serum HER2 levels are increased in cats with mammary carcinomas and predict tissue HER2 status.

Soares M, Ribeiro R, Najmudin S, Gameiro A, Rodrigues R, Cardoso F, Ferreira F
Oncotarget 2016 Apr 5;7(14):17314-26

Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo.

Rowson-Hodel AR, Manjarin R, Trott JF, Cardiff RD, Borowsky AD, Hovey RC
BMC cancer 2015 Jul 31;15:562

Tissue biomarkers in prognostication of serous ovarian cancer following neoadjuvant chemotherapy.

Khandakar B, Mathur SR, Kumar L, Kumar S, Datta Gupta S, Iyer VK, Kalaivani M
BioMed research international 2014;2014:401245

Unraveling the regulatory connections between two controllers of breast cancer cell fate.

Lee J, Tiwari A, Shum V, Mills GB, Mancini MA, Igoshin OA, Balázsi G
Nucleic acids research 2014 Jun;42(11):6839-49

Progesterone and estrogen receptors in conjunctival melanoma and nevi.

Bredow L, Stützel L, Böhringer D, Gundlach E, Reinhard T, Auw-Haedrich C
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2014 Feb;252(2):359-65

Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior.

Kruer TL, Cummins TD, Powell DW, Wittliff JL
Clinical biochemistry 2013 Nov;46(16-17):1739-46

Breast cancer tissue slices as a model for evaluation of response to rapamycin.

Grosso SH, Katayama ML, Roela RA, Nonogaki S, Soares FA, Brentani H, Lima L, Folgueira MA, Waitzberg AF, Pasini FS, Góes JC, Brentani MM
Cell and tissue research 2013 Jun;352(3):671-84

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.

Li Y, Meeran SM, Patel SN, Chen H, Hardy TM, Tollefsbol TO
Molecular cancer 2013 Feb 4;12:9

Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors.

Corrêa NC, Kuasne H, Faria JA, Seixas CC, Santos IG, Abreu FB, Nonogaki S, Rocha RM, Aparecida Borges Silva G, Gobbi H, Rogatto SR, Goes AM, Gomes DA
Oncology reports 2013 Apr;29(4):1299-307

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.

Hovanessian-Larsen L, Taylor D, Hawes D, Spicer DV, Press MF, Wu AH, Pike MC, Pearce CL
Contraception 2012 Sep;86(3):238-43

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation.

Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, Stanczyk FZ, Patel S, Anderson AR, Pike MC, Wu AH, Pearce CL
Breast cancer research and treatment 2012 Apr;132(2):653-60

Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.

Joosse SA, Brandwijk KI, Devilee P, Wesseling J, Hogervorst FB, Verhoef S, Nederlof PM
Breast cancer research and treatment 2012 Apr;132(2):379-89

Logullo AF, Stiepcich MM, Osório CA, Nonogaki S, Pasini FS, Rocha RM, Soares FA, Brentani MM
Histopathology 2011 Mar;58(4):617-25

CDB-4124, a progesterone receptor modulator, inhibits mammary carcinogenesis by suppressing cell proliferation and inducing apoptosis.

Wiehle R, Lantvit D, Yamada T, Christov K
Cancer prevention research (Philadelphia, Pa.) 2011 Mar;4(3):414-24

Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.

Joosse SA, Brandwijk KI, Mulder L, Wesseling J, Hannemann J, Nederlof PM
Genes, chromosomes & cancer 2011 Feb;50(2):71-81

Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.

Niwińska A, Murawska M, Pogoda K
Cancer 2010 Sep 15;116(18):4238-47

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast.

Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D
Breast cancer research and treatment 2009 Nov;118(1):161-8

Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer.

Roepman P, Horlings HM, Krijgsman O, Kok M, Bueno-de-Mesquita JM, Bender R, Linn SC, Glas AM, van de Vijver MJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15;15(22):7003-11

Estrogen and inflammation modulate estrogen receptor alpha expression in specific tissues of the temporomandibular joint.

Puri J, Hutchins B, Bellinger LL, Kramer PR
Reproductive biology and endocrinology : RB&E 2009 Dec 31;7:155

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Horlings HM, van Laar RK, Kerst JM, Helgason HH, Wesseling J, van der Hoeven JJ, Warmoes MO, Floore A, Witteveen A, Lahti-Domenici J, Glas AM, Van't Veer LJ, de Jong D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Sep 20;26(27):4435-41

Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry.

Shi SR, Liu C, Pootrakul L, Tang L, Young A, Chen R, Cote RJ, Taylor CR
American journal of clinical pathology 2008 Mar;129(3):358-66

Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas.

Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, Ferro A, Dalla Palma P, Galligioni E, Marchetti A
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Oct 15;13(20):6064-9

Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.

Inceboz US, Nese N, Uyar Y, Ozcakir HT, Kurtul O, Baytur YB, Kandiloglu AR, Caglar H, Fraser IS
Gynecologic and obstetric investigation 2006;61(1):24-8

Estrogen induced functional hypertrophy and increased force generation of the female rabbit bladder.

Lin AD, Levin R, Kogan B, Whitbeck C, Chichester P, Sokol R, Mannikarottu A
Neurourology and urodynamics 2006;25(5):473-9

Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.

Weroha SJ, Li SA, Tawfik O, Li JJ
Carcinogenesis 2006 Mar;27(3):491-8

The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.

Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA, Topuz S, Tuzlali S, Bengisu E, Berkman S
Gynecologic oncology 2005 Oct;99(1):36-42

Abnormal morphology of the penis in male rats exposed neonatally to diethylstilbestrol is associated with altered profile of estrogen receptor-alpha protein, but not of androgen receptor protein: a developmental and immunocytochemical study.

Goyal HO, Braden TD, Williams CS, Dalvi P, Mansour MM, Mansour M, Williams JW, Bartol FF, Wiley AA, Birch L, Prins GS
Biology of reproduction 2004 May;70(5):1504-17

Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature.

Kuo KT, Chen MJ, Lin MC
The American journal of surgical pathology 2004 Mar;28(3):405-9

Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature.

Kuo KT, Chen MJ, Lin MC
The American journal of surgical pathology 2004 Mar;28(3):405-9

Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors.

Beliakoff J, Bagatell R, Paine-Murrieta G, Taylor CW, Lykkesfeldt AE, Whitesell L
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Oct 15;9(13):4961-71

Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.

Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003 Jan-Feb;13(1):32-7

Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination.

Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.

Zinser GM, McEleney K, Welsh J
Molecular and cellular endocrinology 2003 Feb 28;200(1-2):67-80

Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.

Zinser GM, McEleney K, Welsh J
Molecular and cellular endocrinology 2003 Feb 28;200(1-2):67-80

Expression of CYP3A4 in human breast tumour and non-tumour tissues.

Kapucuoglu N, Coban T, Raunio H, Pelkonen O, Edwards RJ, Boobis AR, Iscan M
Cancer letters 2003 Dec 8;202(1):17-23

Expression of CYP3A4 in human breast tumour and non-tumour tissues.

Kapucuoglu N, Coban T, Raunio H, Pelkonen O, Edwards RJ, Boobis AR, Iscan M
Cancer letters 2003 Dec 8;202(1):17-23

Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases.

Herbert M, Sandbank J, Liokumovich P, Yanai O, Pappo I, Karni T, Segal M
Histopathology 2002 Jul;41(1):30-4

Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases.

Herbert M, Sandbank J, Liokumovich P, Yanai O, Pappo I, Karni T, Segal M
Histopathology 2002 Jul;41(1):30-4

Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma.

Halperin R, Zehavi S, Hadas E, Habler L, Bukovsky I, Schneider D
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2001 Oct;20(4):341-5

Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma.

Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.

Querzoli P, Albonico G, di Iasio MG, Ferretti S, Rinaldi R, Cariello A, Pedriali M, Matteuzzi M, Maestri I, Nenci I
Breast cancer research and treatment 2001 Mar;66(2):135-42

Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women.

Querzoli P, Albonico G, di Iasio MG, Ferretti S, Rinaldi R, Cariello A, Pedriali M, Matteuzzi M, Maestri I, Nenci I
Breast cancer research and treatment 2001 Mar;66(2):135-42

Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome.

Zunarelli E, Nicoll JA, Migaldi M, Trentini GP
Breast cancer research and treatment 2000 Oct;63(3):193-8

Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome.

Zunarelli E, Nicoll JA, Migaldi M, Trentini GP
Breast cancer research and treatment 2000 Oct;63(3):193-8

No comments: Submit comment

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Western blot analysis was performed on modified whole cell extracts (1% SDS) (30 µg lysate) of T-47D (Lane 1), tissue extracts of Mouse Uterus (Lane 2), Rat Uterus (Lane 3), Mouse Ovary (Lane 4), Rat Ovary (Lane 5), Mouse Lung (Lane 6) and Rat Lung (Lane 7). The blot was probed with Anti-Estrogen Receptor alpha Monoclonal Antibody (Product # MA1-80216, 1:1000 dilution) and detected by chemiluminescence using Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, HRP conjugate (Product # A28177, 1:4000 dilution). A 66kDa band corresponding to HSP60 was observed across all cell lines and tissues tested except for Mouse Lung and Rat Lung. A band at 25kDa was also observed in certain tissue extracts.

Supportive validation

Submitted by: Invitrogen Antibodies (provider)
Main image
Experimental details: Immunofluorescence analysis of Estrogen Receptor alpha was performed using 70% confluent log phase MCF7 cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with Estrogen Receptor alpha Monoclonal Antibody (6F11) (Product # MA1-80216) at 1:100 in 0.1% BSA, incubated at 4 degree Celsius overnight and then labeled with Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A28175) at a dilution of 1:2000 for 45 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI (Product # P36962). F-actin (Panel c: red) was stained with Rhodamine Phalloidin (Product # R415). Panel d represents the merged image showing nucleus localization. Panel e represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.